Aligos Therapeutics ALGS
NASDAQ ALGS
$2.10 +0.12 (+6.06%)
At close: Nov 13, 2026 · 4:00 PM EST

Aligos Therapeutics (ALGS) Gains (Losses) on Sale of Assets & Investments (2020 - 2026)

Updated

Aligos Therapeutics' Gains (Losses) on Sale of Assets & Investments came in at -$1,000 for Q2 2026, compared with -$27,000 a year earlier.

Analysis

Aligos Therapeutics (ALGS) Gains (Losses) on Sale of Assets & Investments (2020 - 2026) Analysis & Trends

Over the trailing twelve months to Jun 30, 2026, Aligos Therapeutics reported Gains (Losses) on Sale of Assets & Investments of $22,000, down 24.1% year-over-year; for FY2025, it was $22,000, up 144.4% from FY2024.

  • Gains (Losses) on Sale of Assets & Investments carries a five-year compound annual growth rate of -20.2% (FY2020 to FY2025).
  • Going back by year, Gains (Losses) on Sale of Assets & Investments was $9,000 in FY2024 (-90.6%), $96,000 in FY2023 and -$57,000 in FY2022.
  • The five-year range for quarterly Gains (Losses) on Sale of Assets & Investments is -$248,000 (Q1 2022) to $236,000 (Q4 2022).
  • Business Quant data shows ALGS's Gains (Losses) on Sale of Assets & Investments at -$30,000 (Q1 2026), $18,000 (Q4 2025) and $35,000 (Q3 2025) in the three quarters before Q2 2026.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Gains on Sales (Qtr)
1 Eli Lilly 1,359.75 Bn 1,333.37 Bn 20.46 Bn -
2 Johnson & Johnson 688.76 Bn 608.62 Bn 17.30 Bn -
3 AbbVie 521.69 Bn 489.75 Bn 13.12 Bn -
4 Merck 364.31 Bn 327.31 Bn 13.19 Bn -
5 Novartis Ag 306.35 Bn 279.93 Bn - -
6 Astrazeneca 285.96 Bn 259.56 Bn 13.26 Bn -
7 Amgen 251.88 Bn 203.53 Bn 7.58 Bn -
8 Gilead Sciences 208.59 Bn 183.61 Bn 6.73 Bn -
9 Pfizer 164.73 Bn 112.38 Bn 12.56 Bn -
10 Aligos Therapeutics 21.97 Mn -314.86 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -1,000.00
Mar 31, 2026 -30,000.00
Dec 31, 2025 18,000.00
Sep 30, 2025 35,000.00
Jun 30, 2025 -27,000.00
Mar 31, 2025 -4,000.00
Dec 31, 2024 -23,000.00
Sep 30, 2024 83,000.00
Jun 30, 2024 18,000.00
Mar 31, 2024 -69,000.00
Jun 30, 2023 -2,000.00
Mar 31, 2023 98,000.00
Dec 31, 2022 236,000.00
Sep 30, 2022 109,000.00
Jun 30, 2022 -154,000.00
Mar 31, 2022 -248,000.00
Sep 30, 2021 -1,000.00
Jun 30, 2021 -26,000.00
Mar 31, 2021 -41,000.00
Dec 31, 2020 -64,000.00
API Access

Aligos Therapeutics Gains (Losses) on Sale of Assets & Investments API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=non-operating-investment-income&ticker=ALGS&period=max&api_key=YOUR_API_KEY